Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study publi ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

A phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving with low-dose semaglutide. HealthDay News — Low-dose semaglutide seems to reduce craving and certain ...

Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss.

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Because obesity and obesity-related conditions have been linked to several types of cancer, doctors believe that these ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Animal studies have linked semaglutide (the active ingredient in Ozempic) to a higher risk of thyroid cancer. However, results from animal studies do not always apply to humans. It’s not known ...

a national campaign which spotlights the longstanding Ozempic ® patient community by sharing authentic stories of three multi-talented adults living with type 2 diabetes with help from Ozempic ® ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

PLAINSBORO, N.J., March 3, 2025 /PRNewswire/ -- Novo Nordisk launched "My Ozempic ® Era" today, a national campaign which spotlights the longstanding Ozempic ® patient community by sharing ...